Type 2 diabetes: In a phase 3 clinical trial , tirzepatide lowered A1C levels by 2.34%2.40%, making it significantly more effective at lowering blood sugar levels than semaglutide and other GLP-1s
Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina, told NBC News
At Edge Peptide Therapy, we prioritize patient safety by conducting thorough consultations and lab work to tailor treatments to individual needs
Also, tell your doctor if you are taking other medicines
Khasra No 8/28/2, Kripal Nagar, Baldev Nagar, Ambala Chandigarh Express Highway, Ambala, Haryana, India-134003